123 related articles for article (PubMed ID: 37337403)
41. In vitro inhibitory effect of luotonin A on human CYP1A.
Jahng Y; Kwon OK; Lee S
Arch Pharm Res; 2012 Dec; 35(12):2199-203. PubMed ID: 23263815
[TBL] [Abstract][Full Text] [Related]
42. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.
Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R
Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981
[TBL] [Abstract][Full Text] [Related]
43. Strain differences in hepatic cytochrome P450 1A and 3A expression between Sprague-Dawley and Wistar rats.
Kishida T; Muto S; Hayashi M; Tsutsui M; Tanaka S; Murakami M; Kuroda J
J Toxicol Sci; 2008 Oct; 33(4):447-57. PubMed ID: 18827444
[TBL] [Abstract][Full Text] [Related]
44. Interaction of
Delgado-Roche L; Santes-Palacios R; Herrera JA; Hernández SL; Riera M; Fernández MD; Mesta F; Garrido G; Rodeiro I; Espinosa-Aguirre JJ
Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33227946
[TBL] [Abstract][Full Text] [Related]
45. Isolation of two cytochrome P450 cDNAs, CYP1A1 and CYP1A2, from harp seal (Phoca groenlandica) and grey seal (Halichoerus grypus).
Tilley RE; Kemp GD; Teramitsu I; Hall AJ
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Jun; 132(2):181-91. PubMed ID: 12106895
[TBL] [Abstract][Full Text] [Related]
46. Functional cytochrome P450 1A enzymes are induced in mouse and human islets following pollutant exposure.
Ibrahim M; MacFarlane EM; Matteo G; Hoyeck MP; Rick KRC; Farokhi S; Copley CM; O'Dwyer S; Bruin JE
Diabetologia; 2020 Jan; 63(1):162-178. PubMed ID: 31776611
[TBL] [Abstract][Full Text] [Related]
47. Catalytic and immunochemical properties of hepatic cytochrome P450 1A in three avian species treated with beta-naphthoflavone or isosafrole.
Verbrugge LA; Giesy JP; Verbrugge DA; Woodin BR; Stegeman JJ
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Sep; 130(1):67-83. PubMed ID: 11544144
[TBL] [Abstract][Full Text] [Related]
48. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
49. Major involvement of rabbit liver cytochrome P4501A in thiabendazole 5-hydroxylation.
Rey-Grobellet X; Eeckhoutte C; Sutra JF; Alvinerie M; Galtier P
Xenobiotica; 1996 Jul; 26(7):765-78. PubMed ID: 8819304
[TBL] [Abstract][Full Text] [Related]
50. The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains Is Governed by Their N-terminal and Internal Protein Regions.
Park JW; Reed JR; Backes WL
J Biol Chem; 2015 Dec; 290(49):29449-60. PubMed ID: 26468279
[TBL] [Abstract][Full Text] [Related]
51. A novel gender-related difference in the constitutive expression of hepatic cytochrome P4501A subfamily enzymes in Meishan pigs.
Kojima M; Sekimoto M; Degawa M
Biochem Pharmacol; 2008 Mar; 75(5):1076-82. PubMed ID: 18068149
[TBL] [Abstract][Full Text] [Related]
52. Constitutive and induced expression by pyridine and beta-naphthoflavone of rat CYP1A is sexually dimorphic.
Iba MM; Fung J; Thomas PE; Park Y
Arch Toxicol; 1999; 73(4-5):208-16. PubMed ID: 10463385
[TBL] [Abstract][Full Text] [Related]
53. Palmatine activates AhR and upregulates CYP1A activity in HepG2 cells but not in human hepatocytes.
Vrba J; Havlikova M; Gerhardova D; Ulrichova J
Toxicol In Vitro; 2014 Jun; 28(4):693-9. PubMed ID: 24583342
[TBL] [Abstract][Full Text] [Related]
54. CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.
Uno S; Endo K; Ishida Y; Tateno C; Makishima M; Yoshizato K; Nebert DW
Toxicol Appl Pharmacol; 2009 May; 237(1):119-26. PubMed ID: 19285097
[TBL] [Abstract][Full Text] [Related]
55. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
[TBL] [Abstract][Full Text] [Related]
56. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
Muto S; Fujita K; Yamazaki Y; Kamataki T
Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
[TBL] [Abstract][Full Text] [Related]
57. [Sex- and species-differences on xenobiotic-induced toxicity: differences in constitutive and xenobiotic-mediated expression of cytochrome P450 1A subfamily enzymes (CYP1As)].
Sekimoto M
Yakugaku Zasshi; 2011 Mar; 131(3):415-22. PubMed ID: 21372538
[TBL] [Abstract][Full Text] [Related]
58. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
59. Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues.
Lewis DF; Lake BG
Xenobiotica; 1996 Jul; 26(7):723-53. PubMed ID: 8819302
[TBL] [Abstract][Full Text] [Related]
60. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
